Onconova Therapeutics, Inc. Warrants
ONTXW
ONTXW was delisted on the 23rd of July, 2021.
4 hedge funds and large institutions have $47K invested in Onconova Therapeutics, Inc. Warrants in 2018 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
20% less funds holding
Funds holding: 5 → 4 (-1)
97% less capital invested
Capital invested by funds: $1.5M → $47K (-$1.45M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
6CM
683 Capital Management
New York
|
-$1.37M |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$3.21K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$383 |
ONTXW Hedge Fund Activity: Q4 2018 in Review
4 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Onconova Therapeutics, Inc. Warrants (ONTXW) for Q4 2018, worth a combined $47K — down 97% from $1.5M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of ONTXW and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 0 added.
The largest seller was 683 Capital Management, exiting entirely with an estimated $1.37M sold.
- 4 institutional investors held Onconova Therapeutics, Inc. Warrants (ONTXW) as of Q4 2018, down from 5 in Q3 2018.
- Funds reported $47K of Onconova Therapeutics, Inc. Warrants stock for Q4 2018, down 97% quarter-over-quarter.
- 0 funds opened new Onconova Therapeutics, Inc. Warrants positions in Q4 2018 and 1 closed out, a net change of -1 holder.
- The largest Onconova Therapeutics, Inc. Warrants seller in Q4 2018 was 683 Capital Management, an estimated $1.37M sold.
Based on aggregated 13F filings for Q4 2018.